Ketamine, an anesthetic and pain reliever, is not a standard treatment for opioid withdrawal
How and when you apply it is as important as the product itself
A 2025 European Journal of Clinical Nutrition commentary on the NICE guideline argued that the diagnostic threshold and clinical awareness still need to be tightened further, especially around pernicious anaemia, which is still under-recognised in primary care
Afterward, cell phenotype was examined by testing their senescence level and cartilage formation capacity
For comparisons between two specific groups, the MannWhitney U test was applied
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability